[Heart Team and heart valve diseases: the importance of a multidisciplinary approach].

Heart Team e malattie valvolari: l’importanza di un approccio multidisciplinare.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Jul 2021
Historique:
entrez: 27 6 2021
pubmed: 28 6 2021
medline: 12 10 2021
Statut: ppublish

Résumé

Valvular heart diseases (VHD) are common in the elderly population and several therapeutic options are available to treat them. When selecting the management strategy for VHD patients, to evaluate the operatory risk, using special scores like STS score, EuroSCORE II and other more specific ones is pivotal. However, the risk scores do not consider some aspects, such as the clinical needs of the single patients, the management of local resources and the expertise of the center. The Heart Team, combining the experience of various specialists, can optimize the decision-making process through a better evaluation of the risk/benefit ratio of the therapeutic choices. The multidisciplinary discussion of the most complex cases is recommended by the international guidelines for the management of VHD and it is part of the clinical practice of many centers. So far, both trials and large clinical studies supporting such multidisciplinary management are lacking. Despite these important limitations, the Heart Team can be actually regarded as a promising tool to locally promote best practices for the treatment of VHD patients.

Identifiants

pubmed: 34175912
doi: 10.1714/3629.36107
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

561-569

Auteurs

Silvia Malara (S)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Francesco Burzotta (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Enrico Romagnoli (E)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma.

Cristina Aurigemma (C)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma.

Piergiorgio Bruno (P)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Natalia Pavone (N)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma.

Francesca Graziani (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma.

Carlo Trani (C)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Filippo Crea (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Massimo Massetti (M)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma - Università Cattolica del Sacro Cuore, Roma, Italia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH